RPRX logo
Royalty Pharma plc(RPRX)
Closing price · checked 8:37 PM ETAbout this dataData status
$68.45▲0.73 (1.08%)
Extended:$67.65-0.80 (-1.17%)· 8:37 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Royalty Pharma plc (RPRX)

EBITDA Margin

58.71%

TTM · Period ending:

RPRX logo

RPRX EBITDA Margin

Latest reported58.71%
RPRX EBITDA Margin (52.19% → 58.71%)
High-resolution chart · PNG

What is ebitda margin?

EBITDA as a percentage of revenue.

RPRX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Royalty Pharma plc EBITDA Margin — Annual fiscal periods
Period endingEBITDA MarginChange
68.7794%+0.02 pts
68.7551%−11.40 pts
80.1542%+61.22 pts
18.9385%−43.54 pts
62.4749%−26.20 pts
88.6785%−63.11 pts
151.7933%+49.78 pts
102.0159%+0.40 pts
101.6181%+44.68 pts
56.9408%+4.75 pts
52.1924%—

Frequently asked questions: RPRX ebitda margin

What is Royalty Pharma plc (RPRX)'s current ebitda margin?

Royalty Pharma plc (RPRX)'s latest reported ebitda margin (TTM) is 58.71% as of Sep 30, 2026. EBITDA as a percentage of revenue.

How much historical ebitda margin data is available for RPRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s ebitda margin, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RPRX's ebitda margin to peers or set an alert?

You can open RPRX's ebitda margin in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.